EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy

PURPOSE: The aim of this research was to examine the molecular and clinical features that are related with EGFR-tyrosine kinase inhibitor (EGFR-TKI) efficacy in previously treated patients with squamous cell carcinoma of the lung (SCCL). MATERIALS AND METHODS: This retrospective study included 67 SC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hyun, Oh, Jisu, Zhang, Xianglan, Kim, Yu Jung, Lee, Jae Ho, Lee, Choon-Taek, Chung, Jin-haeng, Lee, Jong-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998034/
https://www.ncbi.nlm.nih.gov/pubmed/27578983
http://dx.doi.org/10.2147/OTT.S107291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998034/
https://www.ncbi.nlm.nih.gov/pubmed/27578983
http://dx.doi.org/10.2147/OTT.S107291

Ejemplares similares